Merck Sharp & Dohme’s
MDS is a research-intensive biopharmaceutical company that develops important medicines and vaccines.
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. New Research and Innovation Centre opens at Launceston General Hospital 2. Hong Kong's pathway for doctors may boost innovation 3. Chinese Medicine Hospital named ‘teaching hub’ for 3 HK universities 4. Saudi Arabia’s Fakeeh Care to pilot AI remote patient monitoring in new partnership 5. IHH Healthcare’s net profit drops 29% to $105m in Q2Resource Center
Read Here
Advertise
Sign Up
Event News
Healthcare Asia Awards 2025 Winner: Tanupol Virunhagarun, M.D. of BDMS Wellness Clinic
Tanupol Virunhagarun, M.
